McKesson Corporation

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +50

McKesson stock faces earnings test with profit growth in focus

Earnings report AI-generated analysis

πŸ“… McKesson is scheduled to release fiscal second-quarter 2027 results after the market close on Wednesday, November 4, 2026.

πŸ’° Analysts expect earnings of $10.72 per share and revenue of $109.90 billion for the upcoming quarter.

πŸ“ˆ Expected performance implies an 8.7% growth in earnings and a 6.5% increase in revenue year-over-year.

πŸ† McKesson has exceeded consensus earnings estimates in six of its last eight quarters, establishing a strong recent track record.

πŸ” The upcoming report will provide critical insights into demand across pharmaceutical distribution, specialty-care, and medical-surgical operations.

βš–οΈ Key investor attention is focused on the company's ability to convert revenue growth into sustained profit margins.

πŸ“‰ Management comments regarding the full-year outlook will be a central point of interest during the earnings call.

Bullish Signals
  • McKesson has demonstrated a strong track record, exceeding consensus earnings estimates in six of its last eight quarters.
  • Analysts project robust growth with expected earnings of $10.72 per share and revenue of $109.90 billion for the fiscal second quarter.
Full Analysis
McKesson Corporation is preparing to report its fiscal second-quarter 2027 earnings on Wednesday, November 4, 2026, following the market close. Analysts anticipate a significant beat in performance, with consensus estimates projecting earnings of $10.72 per share and revenue reaching $109.90 billion. These expected figures represent an 8.7% increase in earnings and a 6.5% rise in revenue compared to the same quarter last year. The company previously reported fiscal first-quarter results on August 5, 2026, where it posted $9.93 per share in earnings and $105.38 billion in revenue. Investors are closely watching this upcoming report to determine if McKesson can sustain its recent track record of beating consensus estimates in six of the last eight quarters. The primary focus will be on whether the company can successfully convert growing revenue into higher profits while maintaining its full-year guidance amidst broader market sentiment.